Renalytix PLC
LSE:RENX
Renalytix PLC
Cash & Cash Equivalents
Renalytix PLC
Cash & Cash Equivalents Peer Comparison
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Renalytix PLC
LSE:RENX
|
Cash & Cash Equivalents
$24.7m
|
CAGR 3-Years
23%
|
CAGR 5-Years
259%
|
CAGR 10-Years
N/A
|
|
Craneware PLC
LSE:CRW
|
Cash & Cash Equivalents
$63.9m
|
CAGR 3-Years
8%
|
CAGR 5-Years
11%
|
CAGR 10-Years
8%
|
|
Cambridge Cognition Holdings PLC
LSE:COG
|
Cash & Cash Equivalents
£3.2m
|
CAGR 3-Years
2%
|
CAGR 5-Years
24%
|
CAGR 10-Years
4%
|
|
Intelligent Ultrasound Group PLC
LSE:IUG
|
Cash & Cash Equivalents
£7.2m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
Instem PLC
LSE:INS
|
Cash & Cash Equivalents
£14m
|
CAGR 3-Years
33%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
EMIS Group PLC
LSE:EMIS
|
Cash & Cash Equivalents
£48.5m
|
CAGR 3-Years
3%
|
CAGR 5-Years
8%
|
CAGR 10-Years
11%
|
See Also
What is Renalytix PLC's Cash & Cash Equivalents?
Cash & Cash Equivalents
24.7m
USD
Based on the financial report for Jun 30, 2023, Renalytix PLC's Cash & Cash Equivalents amounts to 24.7m USD.
What is Renalytix PLC's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
259%
Over the last year, the Cash & Cash Equivalents growth was -40%. The average annual Cash & Cash Equivalents growth rates for Renalytix PLC have been 23% over the past three years , 259% over the past five years .